Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study


KAYA M. F., ÖZKAN M., Gunebakmaz O., Akkaya H., Kaya E. G., Akpek M., ...Daha Fazla

INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.167, sa.5, ss.2306-2310, 2013 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 167 Sayı: 5
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1016/j.ijcard.2012.06.023
  • Dergi Adı: INTERNATIONAL JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2306-2310
  • Anahtar Kelimeler: Nebivolol, Anthracycline, Cardiomyopathy, DOXORUBICIN-INDUCED CARDIOMYOPATHY, METASTATIC BREAST-CANCER, 5-FLUOROURACIL CARDIOTOXICITY, RECEPTOR BLOCKER, HEART-FAILURE, NITRIC-OXIDE, CARVEDILOL, CHEMOTHERAPY, TRIAL, RATS
  • Erciyes Üniversitesi Adresli: Evet

Özet

Background: We aimed to evaluate the effect of prophylactic nebivolol use on prevention of antracycline-induced cardiotoxicity in breast cancer patients.